JPWO2020089841A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020089841A5 JPWO2020089841A5 JP2021523754A JP2021523754A JPWO2020089841A5 JP WO2020089841 A5 JPWO2020089841 A5 JP WO2020089841A5 JP 2021523754 A JP2021523754 A JP 2021523754A JP 2021523754 A JP2021523754 A JP 2021523754A JP WO2020089841 A5 JPWO2020089841 A5 JP WO2020089841A5
- Authority
- JP
- Japan
- Prior art keywords
- nampt
- human subject
- subject
- tissue
- rili
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000015532 Nicotinamide Phosphoribosyltransferase Human genes 0.000 claims 22
- 108010064862 Nicotinamide Phosphoribosyltransferase Proteins 0.000 claims 22
- 239000003795 chemical substances by application Substances 0.000 claims 8
- 210000001519 tissues Anatomy 0.000 claims 8
- 108020004999 Messenger RNA Proteins 0.000 claims 4
- 102000004965 antibodies Human genes 0.000 claims 4
- 108090001123 antibodies Proteins 0.000 claims 4
- 239000012472 biological sample Substances 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 229920002106 messenger RNA Polymers 0.000 claims 4
- 238000001959 radiotherapy Methods 0.000 claims 4
- 210000000481 Breast Anatomy 0.000 claims 2
- 238000002965 ELISA Methods 0.000 claims 2
- 210000004072 Lung Anatomy 0.000 claims 2
- 208000009856 Lung Disease Diseases 0.000 claims 2
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 2
- 210000002741 Palatine Tonsil Anatomy 0.000 claims 2
- 210000002381 Plasma Anatomy 0.000 claims 2
- 238000000376 autoradiography Methods 0.000 claims 2
- 230000000295 complement Effects 0.000 claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 2
- 238000003757 reverse transcription PCR Methods 0.000 claims 2
- 238000001262 western blot Methods 0.000 claims 2
- 208000004852 Lung Injury Diseases 0.000 claims 1
- 206010069363 Traumatic lung injury Diseases 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 238000003364 immunohistochemistry Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 231100000515 lung injury Toxicity 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
Claims (15)
(ii)前記ヒト被験体は電離放射線(IR)に暴露される、
請求項6に記載の方法。 (i) the human subject is a cancer patient undergoing radiotherapy , wherein the human subject may be a cancer patient undergoing thoracic radiotherapy; or
(ii) the human subject is exposed to ionizing radiation (IR) ;
7. The method of claim 6 .
(ii)前記組織は、肺組織、胸部組織、又は扁桃腺組織である、
請求項1に記載の方法。 (i) said healthy control or reference value is the expression level of NAMPT in a control subject, wherein said control subject may be a subject not having RILI and having any lung disease; may be a subject that does not
(ii) the tissue is lung tissue, breast tissue, or tonsil tissue;
The method of claim 1.
(ii)前記ヒト被験体は、RILIの症状を示す、或いは、
(iii)前記ヒト被験体は、RILIを発症するリスクを有している、
請求項9に記載の方法。 (i) said capture agent detects NAMPT mRNA and the binding of NAMPT and said capture agent in step ( b ) is detected by RT-PCR , wherein said capture agent comprises the entire nucleic acid sequence of SEQ ID NO: 1 or partially complementary primer pairs,
(ii) the human subject exhibits symptoms of RILI; or
(iii) the human subject is at risk of developing RILI;
10. The method of claim 9 .
(ii)前記ヒト被験体は電離放射線(IR)に暴露される、
請求項11に記載の方法。 (i) said human subject is a cancer patient undergoing radiotherapy , wherein said human subject may be a cancer patient undergoing thoracic radiotherapy; or
(ii) the human subject is exposed to ionizing radiation (IR);
12. The method of claim 11 .
10. The method of claim 9 , wherein the biological sample is tissue or plasma , wherein the tissue may be lung tissue, breast tissue, or tonsil tissue .
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862753802P | 2018-10-31 | 2018-10-31 | |
US62/753,802 | 2018-10-31 | ||
US201962896483P | 2019-09-05 | 2019-09-05 | |
US62/896,483 | 2019-09-05 | ||
PCT/IB2019/059379 WO2020089841A1 (en) | 2018-10-31 | 2019-10-31 | Biomarkers and methods of use for radiation-induced lung injury |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022509018A JP2022509018A (en) | 2022-01-20 |
JPWO2020089841A5 true JPWO2020089841A5 (en) | 2022-11-08 |
Family
ID=68542675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021523754A Pending JP2022509018A (en) | 2018-10-31 | 2019-10-31 | Biomarkers and usage for radiation-induced lung injury |
Country Status (7)
Country | Link |
---|---|
US (2) | US11733242B2 (en) |
EP (1) | EP3874273B1 (en) |
JP (1) | JP2022509018A (en) |
CN (1) | CN113614535A (en) |
AU (1) | AU2019371161A1 (en) |
CA (1) | CA3117112A1 (en) |
WO (1) | WO2020089841A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220403412A1 (en) * | 2021-06-11 | 2022-12-22 | Hui JING | Baculovirus Of Recombinant Superoxide Dismutase Gene, Preparation And Application Thereof |
CN114578058A (en) * | 2022-02-09 | 2022-06-03 | 中国人民解放军军事科学院军事医学研究院 | Application of radiation damage marker BPIFA2 and related kit and reagent thereof |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US4415723A (en) | 1982-03-19 | 1983-11-15 | General Electric Company | Randomly branched aromatic polycarbonate from triphenol |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
DE3785591T2 (en) | 1986-01-10 | 1993-09-02 | Amoco Corp | COMPETITIVE HOMOGENEOUS TEST. |
IL86724A (en) | 1987-06-19 | 1995-01-24 | Siska Diagnostics Inc | Method and kits for the amplification and detection of nucleic acid sequences |
EP0359789B1 (en) | 1988-01-21 | 1993-08-04 | Genentech, Inc. | Amplification and detection of nucleic acid sequences |
CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
US5932413A (en) | 1988-04-01 | 1999-08-03 | Celebuski; Joseph Eugene | DNA probe assay using neutrally charged probe strands |
US5187260A (en) | 1988-09-06 | 1993-02-16 | Sharifa Karali | Process for the preparation of a high purity protamine-DNA complex and process for use of same |
US5856092A (en) | 1989-02-13 | 1999-01-05 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
US5075212A (en) | 1989-03-27 | 1991-12-24 | University Of Patents, Inc. | Methods of detecting picornaviruses in biological fluids and tissues |
US5849481A (en) | 1990-07-27 | 1998-12-15 | Chiron Corporation | Nucleic acid hybridization assays employing large comb-type branched polynucleotides |
US5645987A (en) | 1990-09-21 | 1997-07-08 | Amgen Inc. | Enzymatic synthesis of oligonucleotides |
US5846717A (en) | 1996-01-24 | 1998-12-08 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
US5849486A (en) | 1993-11-01 | 1998-12-15 | Nanogen, Inc. | Methods for hybridization analysis utilizing electrically controlled hybridization |
US5846708A (en) | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
FR2685346B1 (en) | 1991-12-18 | 1994-02-11 | Cis Bio International | PROCESS FOR THE PREPARATION OF DOUBLE-STRANDED RNA, AND ITS APPLICATIONS. |
ES2210239T3 (en) | 1992-04-01 | 2004-07-01 | The Johns Hopkins University School Of Medicine | METHOD FOR DETECTING NUCLEIC ACIDS OF MAMMALS ISOLATED IN MAKES AND REAGENTS FOR THE SAME. |
US5843640A (en) | 1992-06-19 | 1998-12-01 | Northwestern University | Method of simultaneously detecting amplified nucleic acid sequences and cellular antigens in cells |
US5861244A (en) | 1992-10-29 | 1999-01-19 | Profile Diagnostic Sciences, Inc. | Genetic sequence assay using DNA triple strand formation |
US5658751A (en) | 1993-04-13 | 1997-08-19 | Molecular Probes, Inc. | Substituted unsymmetrical cyanine dyes with selected permeability |
US5279721A (en) | 1993-04-22 | 1994-01-18 | Peter Schmid | Apparatus and method for an automated electrophoresis system |
GB9311386D0 (en) | 1993-06-02 | 1993-07-21 | Pna Diagnostics As | Nucleic acid analogue assay procedures |
US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
GB2284208A (en) | 1993-11-25 | 1995-05-31 | Pna Diagnostics As | Nucleic acid analogues with a chelating functionality for metal ions |
DE69432919T2 (en) | 1993-12-28 | 2004-05-27 | Tanabe Seiyaku Co., Ltd. | Methods for the detection of specific polynucleotides |
US5599668A (en) | 1994-09-22 | 1997-02-04 | Abbott Laboratories | Light scattering optical waveguide method for detecting specific binding events |
ATE340866T1 (en) | 1994-10-28 | 2006-10-15 | Gen Probe Inc | COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION AND QUANTIFICATION OF A MAJORITY OF SPECIFIC NUCLIC ACID SEQUENCES |
US5889136A (en) | 1995-06-09 | 1999-03-30 | The Regents Of The University Of Colorado | Orthoester protecting groups in RNA synthesis |
US5929227A (en) | 1995-07-12 | 1999-07-27 | The Regents Of The University Of California | Dimeric fluorescent energy transfer dyes comprising asymmetric cyanine azole-indolenine chromophores |
US5916779A (en) | 1995-09-21 | 1999-06-29 | Becton, Dickinson And Company | Strand displacement amplification of RNA targets |
US5866331A (en) | 1995-10-20 | 1999-02-02 | University Of Massachusetts | Single molecule detection by in situ hybridization |
US5851772A (en) | 1996-01-29 | 1998-12-22 | University Of Chicago | Microchip method for the enrichment of specific DNA sequences |
US5912124A (en) | 1996-06-14 | 1999-06-15 | Sarnoff Corporation | Padlock probe detection |
US5853990A (en) | 1996-07-26 | 1998-12-29 | Edward E. Winger | Real time homogeneous nucleotide assay |
EP0955999B1 (en) | 1996-08-19 | 2001-12-05 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Novel liposome complexes for increased systemic delivery |
US5853992A (en) | 1996-10-04 | 1998-12-29 | The Regents Of The University Of California | Cyanine dyes with high-absorbance cross section as donor chromophores in energy transfer labels |
US5853993A (en) | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
US5900481A (en) | 1996-11-06 | 1999-05-04 | Sequenom, Inc. | Bead linkers for immobilizing nucleic acids to solid supports |
US5905024A (en) | 1996-12-17 | 1999-05-18 | University Of Chicago | Method for performing site-specific affinity fractionation for use in DNA sequencing |
US5846729A (en) | 1997-02-27 | 1998-12-08 | Lorne Park Research, Inc. | Assaying nucleotides in solution using a fluorescent intensity quenching effect |
US5846726A (en) | 1997-05-13 | 1998-12-08 | Becton, Dickinson And Company | Detection of nucleic acids by fluorescence quenching |
US5928869A (en) | 1997-05-30 | 1999-07-27 | Becton, Dickinson And Company | Detection of nucleic acids by fluorescence quenching |
US5919626A (en) | 1997-06-06 | 1999-07-06 | Orchid Bio Computer, Inc. | Attachment of unmodified nucleic acids to silanized solid phase surfaces |
US5935791A (en) | 1997-09-23 | 1999-08-10 | Becton, Dickinson And Company | Detection of nucleic acids by fluorescence quenching |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
EP2314700A1 (en) | 1999-01-28 | 2011-04-27 | Medical College of Georgia Research Institute, Inc | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA |
WO2001012654A2 (en) | 1999-08-18 | 2001-02-22 | Ramot University Authority For Applied Research & Industrial Development Ltd. | Orally active peptides that prevent cell damage and death |
AU2001245793A1 (en) | 2000-03-16 | 2001-09-24 | Cold Spring Harbor Laboratory | Methods and compositions for rna interference |
AU2001297913A1 (en) | 2000-10-13 | 2002-12-23 | Ligocyte Pharmaceuticals, Inc. | Polyvalent nanoparticles |
CA2453417A1 (en) | 2001-07-10 | 2003-06-26 | North Carolina State University | Nanoparticle delivery vehicle |
WO2005065721A2 (en) | 2003-12-30 | 2005-07-21 | Board Of Regents, The University Of Texas System | Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex |
US9409983B2 (en) | 2009-07-23 | 2016-08-09 | The Board Of Trustess Of The University Of Illinois | Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases |
WO2011109650A1 (en) | 2010-03-03 | 2011-09-09 | The Board Of Trustees Of The University Of Illinois | Method of treating acute lung injury using sphingosine 1 phosphate analoges or sphingosine 1 phosphate receptor agonists |
CN103961691A (en) * | 2013-02-03 | 2014-08-06 | 复旦大学 | Application of nicotinamide phosphoribosyltransferase in preparation of neuroprotective drugs |
ITTO20130356A1 (en) * | 2013-05-03 | 2014-11-04 | Uni Degli Studi Del Piemonte Orientale Ame | NICOTINAMID INHIBITORS FOSFORIBOSIL TRANSFERASE, RELATED COMPOSITIONS, PRODUCTS AND USES |
WO2017041114A2 (en) | 2015-09-03 | 2017-03-09 | The Children's Mercy Hospital | Anti-nicotinamide phosphoribosyltransferase antibody genes and methods of use thereof |
WO2018191751A1 (en) | 2017-04-14 | 2018-10-18 | Arizona Board Of Regents On Behalf Of The University Of Arizonia | Compositions and methods for treating pulmonary fibrosis |
WO2018191747A1 (en) | 2017-04-14 | 2018-10-18 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treating pulmonary arterial hypertension |
JP2022543658A (en) | 2019-08-07 | 2022-10-13 | アクアラン セラピューティクス コーポレーション | Anti-NAMPT antibody and use thereof |
US20220290246A1 (en) | 2019-08-07 | 2022-09-15 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Single nucleotide polymorphisms and uses thereof |
WO2022032135A1 (en) | 2020-08-07 | 2022-02-10 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Single nucleotide polymorphisms and treatment of inflammatory conditions |
-
2019
- 2019-10-31 AU AU2019371161A patent/AU2019371161A1/en active Pending
- 2019-10-31 EP EP19802268.3A patent/EP3874273B1/en active Active
- 2019-10-31 CN CN201980087173.2A patent/CN113614535A/en active Pending
- 2019-10-31 WO PCT/IB2019/059379 patent/WO2020089841A1/en unknown
- 2019-10-31 CA CA3117112A patent/CA3117112A1/en active Pending
- 2019-10-31 US US16/670,880 patent/US11733242B2/en active Active
- 2019-10-31 JP JP2021523754A patent/JP2022509018A/en active Pending
-
2023
- 2023-08-21 US US18/453,286 patent/US20240085422A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109765378B (en) | Novel marker for liver cirrhosis or liver fibrosis | |
Takehara et al. | Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4 | |
ES2713648T3 (en) | Method to determine radiosensitivity | |
Hmmier et al. | Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry | |
JP2012512389A5 (en) | ||
BR112012013418B1 (en) | BIOCHEMICAL SERIC MARKER | |
JPWO2006043362A1 (en) | New diagnostic kit for malignant melanoma | |
Huang et al. | Discriminating value of calprotectin in disease activity and progression of nonradiographic axial spondyloarthritis and ankylosing spondylitis | |
ES2772701T3 (en) | Use of cell-free nucleosomes as biomarkers in sputum samples | |
US20200209244A1 (en) | Tumor blood marker, use thereof, and kit comprising the same | |
CN104812914B (en) | Method for diagnosing liver cancer in subject and kit for diagnosing liver cancer | |
CN107255711A (en) | Osteopontin is used for the purposes for preparing or screening acute-on-chronic liver failure diagnostic reagent | |
JP6361943B2 (en) | Pancreatic cancer diagnostic kit comprising an antibody that specifically binds to complement factor B protein and an antibody that specifically binds to sugar chain antigen 19-9 protein | |
US20130034868A1 (en) | Method and use for assessing radiation therapy in accordance with saa | |
JPWO2020089841A5 (en) | ||
KR102415457B1 (en) | Multiple Biomarkers for Lung Cancer Diagnosis and Uses thereof | |
WO2016143805A1 (en) | Method for detecting bladder cancer | |
CN105203763B (en) | A kind of test kit of oral cancer specific detection | |
Lee et al. | Salivary scavenger and agglutinin (SALSA) is expressed in mucosal epithelial cells and decreased in bronchial epithelium of asthmatic horses | |
JP4336898B2 (en) | Diagnostic agent for malignant melanoma | |
ES2891530T3 (en) | Method for determining mutations of BRAF and wild-type BRAF protein by mass spectrometry | |
Wu et al. | Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma | |
TW202122584A (en) | Method and application thereof for predicting prognosis of cancer | |
KR102599695B1 (en) | Method for detection of lung adenocarcinoma recurrence based on marker human epididymal protein 4 (HE4) and associated uses | |
TW201030337A (en) | Method and kit for detecting cancers |